Literature DB >> 6987010

A microassay for active and total renin concentration in human plasma based on antibody trapping.

J A Millar, B J Leckie, J J Morton, J Jordan, M Tree.   

Abstract

We have developed and validated a new enzyme-kinetic method for measurement of renin concentration (PRC) in human plasma, based on radioimmunoassay of angiotensin I generated during incubation of plasma and excess sheep or ox renin substrate. Angiotensin I breakdown during incubation is prevented by the presence of anti-angiotensin I serum. The assya does not require prior extraction of renin, is technically simple, and is sufficiently sensitive to measure subnormal renin levels. With minor modifications both "active and "total" renin may be measured. Assay results have been calibrated with the International Standard Renin. PRC measured by this technique correlates significantly with angiotensin I and II, plasma renin activity, and with the PRC method previously used by us.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987010     DOI: 10.1016/0009-8981(80)90050-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

1.  Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

Authors:  N Benjamin; J R Cockcroft; J G Collier; C T Dollery; J M Ritter; D J Webb
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

2.  Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.

Authors:  S Sonkodi; E Agabiti-Rosei; R Fraser; B J Leckie; J J Morton; A M Cumming; V P Sood; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

3.  The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension.

Authors:  S Capewell; C G Wathen; W J Hannan; A L Muir
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.

Authors:  A B Atkinson; A M Cumming; J J Brown; R Fraser; B Leckie; A F Lever; J J Morton; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

5.  Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.

Authors:  J A Millar; R Fraser; P Mason; B Leckie; A M Cumming; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

6.  Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.

Authors:  J R Zabludowski; C Zoccali; C G Isles; G D Murray; J I Robertson; G C Inglis; R Fraser; S G Ball
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

7.  Early treatment with captopril after acute myocardial infarction.

Authors:  S G Ray; M Pye; K G Oldroyd; J Christie; D T Connelly; D B Northridge; I Ford; J J Morton; H J Dargie; S M Cobbe
Journal:  Br Heart J       Date:  1993-03

8.  The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man.

Authors:  C Zoccali; J R Zabludowski; C G Isles; G D Murray; G C Inglis; J I Robertson; R Fraser; S G Ball
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

9.  Hypertension associated with increased renin concentrations in nephroblastoma.

Authors:  A B Khan; R Carachi; B J Leckie; G B Lindop
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

10.  Changes in atrial natriuretic factor and plasma renin activity in dogs infected with Trypanosoma brucei.

Authors:  J M Ndung'u; N G Wright; F W Jennings; M Murray
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.